"Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial"
If the concentration halves, the draw volume for the same target amount doubles
FACS confirmed that the results are consistent with the observation (Figure 3C)
Similarly, the other incretin hormone, GIP is efficiently cleaved by DPP-4 in vivo (40), and DPP-4 inhibition increases intact GIP levels and enhances its effects (41)
Note: If you contract with more than one plan in a service area for the same product type (i.e., PPO or Traditional), you may file the claim with either Plan
Dardik R, Varon D, Tamarin I, Zivelin A, Salomon O, Shenkman B, and Savion N (2000)